HomeHOPHF • OTCMKTS
add
Hemogenyx Pharmaceuticals PLC
Previous close
$0.010
Year range
$0.010 - $0.20
Market cap
17.17M GBP
Avg Volume
4.20K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 671.16K | -69.40% |
Net income | -1.18M | 16.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -613.35K | 71.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.25M | -50.74% |
Total assets | 6.11M | -13.91% |
Total liabilities | 3.32M | -13.62% |
Total equity | 2.78M | — |
Shares outstanding | 1.34B | — |
Price to book | ∞ | — |
Return on assets | -27.48% | — |
Return on capital | -29.30% | — |
Cash Flow
Net change in cash
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.18M | 16.90% |
Cash from operations | -1.36M | -37.87% |
Cash from investing | -36.74K | 82.53% |
Cash from financing | 424.74K | 911.34% |
Net change in cash | -918.63K | 43.76% |
Free cash flow | -255.58K | 82.99% |
About
Founded
2013
Website
Employees
17